HSGI-01-P590 - QAPEX 2025 Qatar's Advancement in Pediatric Excellence

Monday, October 20, 2025, 8:00 AM - Tuesday, October 20, 2026, 8:00 PM, Al-sharq hotel, Doha, Qatar


DHP Credits - Category 1 (14.25 hours), Non-Physician Participation Credit (14.25 hours)

QAPEX 2025, a two-day event, aims to advance pediatric care by enhancing professional expertise, fostering collaboration, and promoting evidence-based practices. Through interactive sessions for healthcare providers and parents, it supports Sidra Medicine’s vision by raising care standards, advancing research, empowering families, and strengthening regional leadership in child health.

1. To advance and skills through evidence-based practices and cutting-edge research, ultimately enhancing patient outcomes in child healthcare.
2. To foster inter professional collaboration and networking among pediatric healthcare professionals from local, regional, and international communities
3. To provide interactive and practical learning experiences, including sessions, lectures, and workshops, specifically tailored for front-line child healthcare professionals.

Sidra Medicine has met the accreditation standards and requirements and is accredited as a provider of Continuing Professional Development (CPD) for healthcare practitioners by the Department of Healthcare Professions (DHP), State of Qatar.

In support of improving patient care, Sidra Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

Mitigation of Relevant Financial Relationships

Sidra Medicine adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers or others are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.